Healthcare >> CEO Interviews >> July 8, 2002
DR. LAWRENCE E. BLOCH has been Chief Financial Officer of Applied
Molecular Evolution, Inc., since March 2000 and Secretary since
April 2000. From 1999 to 2002 he was Vice President of Business
Development. From 1998 to 1999, he served as a consultant to
several private biotechnology companies, including Applied
Molecular Evolution and U.S. Genomics, Inc. In 1995, Dr. Bloch
co-founded CareCom, Inc., a developer of patient-oriented
bioinformatics applications, and served as its President from
1995 to 1999. Dr. Bloch received a JD from Harvard Law School, an
MD from Harvard Medical School and an MBA from Harvard Business
School. Dr. Bloch is also a member of the Board of Directors of
AME's subsidiary, Novasite Pharmaceuticals, Inc. Profile
TWST: Could we start out with an update on Applied Molecular Evolution?What has gone on over the past couple of quarters that investors should
focus on?
Dr. Bloch: Since December 2001 we've